The Vanguard Group 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 8,800,843 11.660% | 1,461,323 (+19.91%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 7,339,520 10.210% | 155,828 (+2.17%) | Filing |
| 2022-07-11 1:13 pm Purchase | 2022-06-30 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 7,183,692 10.070% | 294,783 (+4.28%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 6,888,909 9.740% | 687,942 (+11.09%) | Filing |
| 2021-02-10 11:40 am Purchase | 2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT | The Vanguard Group | 6,200,967 9.090% | 759,327 (+13.95%) | Filing |